false
Catalog
PCSS-MOUD On-Demand Webinar: Medications for Opioi ...
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The presentation addresses opioid use disorder (OUD) treatment in correctional settings, emphasizing medication-assisted treatment (MOUD) for justice-involved individuals. It outlines the prevalence of OUD among incarcerated populations, the heightened risk of overdose post-release, and the underutilization of MOUD in jails and prisons. The discussion highlights legal and policy developments, like litigation and Medicaid changes, promoting MOUD access. Evidence shows MOUD increases post-release treatment engagement and reduces opioid use and overdoses. The presentation covers key medications—methadone, buprenorphine, and naltrexone—highlighting their effectiveness and challenges, such as diversion. It stresses individualized treatment plans and the importance of implementing transition strategies to ensure continuity of care post-release. The discussion includes practical approaches to minimize diversion, such as direct observation of medication intake and use of long-acting injections. The team-based approach involving healthcare providers, peers, and correctional staff is critical for effective implementation. The overarching message is that offering MOUD is lifesaving, and efforts must continue to standardize and broaden treatment access across varied correctional facilities.
Keywords
methamphetamine
addiction treatment
novel strategy
cardiovascular issues
contingency management
motivational interviewing
naloxone
bupropion
fentanyl
opioid use disorder
medication-assisted treatment
correctional settings
post-release overdose
MOUD access
transition strategies
legal developments
team-based approach
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English